← Back to Search

Diagnostic Imaging

XFM-Guided Catheterization for Congenital Heart Defects

Waitlist Available
Led By Joshua Kanter, MD
Research Sponsored by Joshua Kanter
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Screening 3 weeks
Treatment Varies
Follow Up at the end of each catheterization procedure through study completion,up to 8 years.
Awards & highlights

Study Summary

This trial will determine if using x-rays fused with MR images can help guide catheter tools during cardiac procedures.

Who is the study for?
This trial is open to children and adults of any age who need a heart catheterization for diagnostic or treatment purposes. It's not suitable for those with unstable heart conditions, pregnant or nursing women (unless they can discard breast milk for 24 hours), or anyone with certain metal implants that are unsafe in MRI machines.Check my eligibility
What is being tested?
The study is testing the use of XFM, which combines x-ray and MRI imaging, to guide catheters during heart procedures. The goal is to see if this method improves the accuracy and safety of these medical interventions.See study design
What are the potential side effects?
Since XFM guidance is an imaging technique rather than a drug, it doesn't have typical side effects. However, there may be risks associated with exposure to radiation from x-rays and potential issues related to being in an MRI machine.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the end of each catheterization procedure through study completion,up to 8 years.
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of each catheterization procedure through study completion,up to 8 years. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Radiation exposure measurement
Secondary outcome measures
Contrast volume measurement
Procedure time measurement

Trial Design

1Treatment groups
Experimental Treatment
Group I: XFM guidanceExperimental Treatment1 Intervention
X-ray fused cardiac MRI images used for guidance tool to perform cardiac catheterization procedure
First Studied
Drug Approval Stage
How many patients have taken this drug
XFM guidance

Find a Location

Who is running the clinical trial?

Joshua KanterLead Sponsor
1 Previous Clinical Trials
50 Total Patients Enrolled
Joshua Kanter, MDPrincipal InvestigatorChildren's National Hospital System
2 Previous Clinical Trials
132 Total Patients Enrolled

Media Library

XFM guidance (Diagnostic Imaging) Clinical Trial Eligibility Overview. Trial Name: NCT02737579 — N/A
Congenital Heart Defects Research Study Groups: XFM guidance
Congenital Heart Defects Clinical Trial 2023: XFM guidance Highlights & Side Effects. Trial Name: NCT02737579 — N/A
XFM guidance (Diagnostic Imaging) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02737579 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies in this medical experiment that participants can fill?

"As per the clinicaltrials.gov database, this medical trial is no longer enrolling participants at present time. The research was initially posted on July 23rd 2013 and underwent its last update on March 28th 2022. Nevertheless, there are still 99 other trials actively seeking to add patients to their studies as we speak."

Answered by AI
Recent research and studies
~2 spots leftby Apr 2025